JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

Pfizer

Cerrado

SectorSalud

24.31 -1.58

Resumen

Variación precio

24h

Actual

Mínimo

24.2

Máximo

25.19

Métricas clave

By Trading Economics

Ingresos

-45M

2.9B

Ventas

938M

15B

P/B

Media del Sector

13.106

37.003

BPA

0.78

Rentabilidad por dividendo

6.87

Margen de beneficio

19.982

Empleados

81,000

EBITDA

266M

5.3B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+15.98% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.87%

2.25%

Fecha Próximo Dividendo

1 dic 2025

Próxima Fecha de Ex Dividendo

7 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

7.1B

141B

Apertura anterior

25.89

Cierre anterior

24.31

Noticias sobre sentimiento de mercado

By Acuity

52%

48%

298 / 373 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Pfizer Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 nov 2025, 12:29 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Pfizer 3Q Profit Falls Amid Lower Covid-19 Drug Demand -- Update

4 nov 2025, 12:12 UTC

Ganancias

Pfizer 3Q Profit Falls Amid Lower Covid-19 Drug Demand

4 nov 2025, 22:10 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 19:39 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- Update

4 nov 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera -- Barrons.com

4 nov 2025, 18:11 UTC

Ganancias

Pfizer 3Q Profit Falls Amid Lower Covid-19 Drug Demand -- 2nd Update

4 nov 2025, 17:59 UTC

Ganancias

Pfizer Stock Slips. Under the Surface, Earnings Weren't Great. -- Barrons.com

4 nov 2025, 17:26 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera -- Barrons.com

4 nov 2025, 16:01 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- WSJ

4 nov 2025, 15:17 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss Drug Startup Metsera -- WSJ

4 nov 2025, 14:58 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Sweetens Offer for Metsera -- WSJ

4 nov 2025, 14:37 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk: Proposal Is Subject to Terms of Pfizer's Merger Pact With Metsera

4 nov 2025, 14:35 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Says Offer Highlights Commitment to Investing in U.S., Interest in Growing Scale of U.S. Investments

4 nov 2025, 14:34 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Believes Proposal, Including Structure, Complies With Applicable Laws and Is in Best Interest of Patients

4 nov 2025, 14:33 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Offers $62.20 a Share in Cash and Up to $24 a Share Based on Certain Milestones

4 nov 2025, 14:32 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Confirms Updated Bid For Metsera

4 nov 2025, 14:12 UTC

Adquisiciones, fusiones, absorciones

Metsera Says Pfizer Merger Agreement Remains in Effect >MTSR

4 nov 2025, 14:12 UTC

Adquisiciones, fusiones, absorciones

Metsera, Pfizer May Negotiate Potential Adjustments for Two Business Days >MTSR

4 nov 2025, 14:12 UTC

Adquisiciones, fusiones, absorciones

Metsera: Novo Nordisk Offer Superior to Revised Pfizer Proposal That Valued It at Up to $ 70/Shr, a Total of About $8.1B >MTSR

4 nov 2025, 14:11 UTC

Adquisiciones, fusiones, absorciones

Metsera: Novo Nordisk's Amended Proposal Values It at Up to $ 86.20/Shr, a Total of About $ 10.0B >MTSR

4 nov 2025, 14:10 UTC

Adquisiciones, fusiones, absorciones

Metsera Receives Amended Proposal From Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal 'Superior'

4 nov 2025, 12:37 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Pfizer Stock Slips on Third-Quarter Earnings. What Covid-19 Has to Do With It. -- Barrons.com

4 nov 2025, 12:02 UTC

Ganancias

Pfizer Stock Rises on Third-Quarter Earnings. Here's Why. -- Barrons.com

4 nov 2025, 11:49 UTC

Ganancias

Pfizer: On Track to Deliver $7.2B Net Cost Savings From Cost-Improvement Initiatives by End 2027 >PFE

4 nov 2025, 11:47 UTC

Ganancias

Pfizer: Expect to Continue to De-Lever in Prudent Manner to Maintain Balanced Capital-Allocation Strategy >PFE

4 nov 2025, 11:47 UTC

Ganancias

Pfizer: Current Financial Guidance Doesn't Anticipate Any Share Buybacks in 2025 >PFE

4 nov 2025, 11:46 UTC

Ganancias

Pfizer: 2025 Guidance Absorbs Impact of Currently Imposed Tariffs From China, Canada, Mexico >PFE

4 nov 2025, 11:46 UTC

Ganancias

Pfizer Backs 2025 View of Rev $61B-$64B >PFE

4 nov 2025, 11:45 UTC

Ganancias

Pfizer Had Seen 2025 Adjusted EPS $2.90-$3.10 >PFE

4 nov 2025, 11:45 UTC

Ganancias

Pfizer 3Q Rev $16.65B >PFE

Comparación entre iguales

Cambio de precio

Pfizer Esperado

Precio Objetivo

By TipRanks

15.98% repunte

Estimación a 12 meses

Media 28.6 USD  15.98%

Máximo 34 USD

Mínimo 24 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

17 ratings

4

Comprar

12

Mantener

1

Vender

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

298 / 373 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat